missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Mouse VEGFR2/KDR/Flk-1 Antibody, R&D Systems™

Rat Monoclonal Antibody has been used in 5 publications
Brand: R&D Systems MAB4431-100
This item is not returnable.
View return policy
Description
VEGFR2/KDR/Flk-1 Monoclonal specifically detects VEGFR2/KDR/Flk-1 in Mouse samples. It is validated for Neutralization, ELISA Capture (Matched Antibody Pair).
Specifications
| VEGFR2/KDR/Flk-1 | |
| Monoclonal | |
| Unconjugated | |
| Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
| CD309, CD309 antigen, EC 2.7.10, EC 2.7.10.1, Fetal liver kinase 1, fetal liver kinase-1, Flk1, Flk-1, FLK1tyrosine kinase growth factor receptor, KDR, Kinase insert domain receptor, kinase insert domain receptor (a type III receptor tyrosine kinase), KRD1, Ly73, Protein-tyrosine kinase receptor flk-1, soluble VEGFR2, vascular endothelial growth factor receptor 2, VEGF R2, VEGFR, VEGFR2, VEGFR-2 | |
| Rat | |
| Protein A or G purified from hybridoma culture supernatant | |
| RUO | |
| 3791 | |
| Reconstitute at 0.5 mg/mL in sterile PBS. | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
| IgG2a |
| Neutralization, ELISA | |
| 91202 | |
| Neutralization 0.05-0.15 ug/mL, ELISA Capture (Matched Antibody Pair) 2-8 ug/mL | |
| P35918 | |
| KDR | |
| Mouse myeloma cell line NS0-derived recombinant mouse VEGFR2, Ala20-Glu762, Accession # P35918 | |
| 100 μg | |
| Primary | |
| Detects mouse VEGFR2 in Western blots. | |
| Mouse | |
| Supernatant |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction